Sopharma AD (the “Company”) notifies that for April 2013 Sopharma AD realized same level of sales revenues compared to the same period of 2012, including 3% increase of domestic sales and 1% decrease of export sales.
During the past four months Sopharma AD recorded a decrease of sales revenues of 3%, including 4% increase of domestic sales and 6% decrease of export sales compared to 2012.
SOPHARMA AD (the “Company”) hereby informs that from 25 April 2013 up to and including 8 May 2013 the Company bought 108089 own shares representing 0.082% of the share capital of the Company, to the total value of BGN 281132.57 on the Bulgarian Stock Exchange.
The average price per share was BGN 2.60.The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.
The total number of own shares after these transactions is 4113757, representing 3.12% of the share capital of the Company.
Pursuant to art.100k, par.1 of POSA we hereby notify, that the Board of Directors of Sopharma AD authorized the Executive Director to begin negotiations for the sale of all shares representing 85% of the capital of the subsidiary Extab Corporation, owned by Sopharma AD. The negotiations will be conducted as part of the strategy for development of the original products of Sopharma AD on new markets, on which the Company does not possess the necessary resources for such actions in the near future.
SOPHARMA AD (the “Company”) hereby informs that from 9 May 2013 up to and including 15 May 2013 the Company bought 14244 own shares representing 0.01% of the share capital of the Company, to the total value of BGN 38501.05 on the Bulgarian Stock Exchange. The average price per share was BGN 2.70.
The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.
The total number of own shares after these transactions is 4128001, representing 3.13% of the share capital of the Company.
SOPHARMA AD (the “Company”) hereby informs that from 16 May 2013 up to and including 22 May 2013 the Company bought 48520 own shares representing 0.037% of the share capital of the Company, to the total value of BGN 139248.98 on the Bulgarian Stock Exchange. The average price per share was BGN 2.87.
The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.
The total number of own shares after these transactions is 4176521, representing 3.16% of the share capital of the Company.
SOPHARMA AD (the “Company”) hereby informs that from 23 May 2013 up to and including 29 May 2013 the Company bought 24,881 own shares representing 0.019% of the share capital of the Company, to the total value of BGN 72,023.21 on the Bulgarian Stock Exchange. The average price per share was BGN 2.93.
The shares have been bought on the basis of decision No. 7 of the General Meeting from 23 June 2010.
The total number of treasury shares after these transactions is 4,201,402, representing 3.18% of the share capital of the Company.
Sopharma AD (the “Company”) notifies that for May 2013 Sopharma AD realized an increase of sales revenues of 22 % compared to the same period of 2012, including 1% increase of domestic sales and 30% increase of export sales. During the past five months Sopharma AD recorded an increase of sales revenues of 1%, including 4% increase of domestic sales and 1% increase of export sales compared to 2012.
SOPHARMA AD (the “Company”) hereby informs that from 30 May 2013 up to and including 5 June 2013 the Company bought 77078 own shares representing 0.058% of the share capital of the Company, to the total value of BGN 228851.01 on the Bulgarian Stock Exchange. The average price per share was BGN 2.97.
The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.
The total number of own shares after these transactions is 4278480, representing 3.24% of the share capital of the Company.
Sopharma AD (the “Company”) announces that on 4 June 2013 the Company sold 156 000 ordinary registered shares with voting rights of the capital of United Holding Doverie AD. After this transaction, the share of Sopharma AD in the capital of United Holding Doverie AD decreased to 9.90%.
SOPHARMA AD (the “Company”) hereby informs that from 6 June 2013 up to and including 12 June 2013 the Company bought 46607 own shares representing 0.035% of the share capital of the Company, to the total value of BGN 143731.48 on the Bulgarian Stock Exchange. The average price per share was BGN 3.08.
The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.
The total number of own shares after these transactions is 4325087, representing 3.28% of the share capital of the Company.
